Broome Oncology

Latest Cancer News

Novel Agent Granted Fast Track Designation for Refractory Metastatic Colorectal Cancer (10-23-2014)
The U.S. Food and Drug Administration (FDA) has granted Fast Track designation to TAS-102, a novel agent currently under investigation for the treatment of refractory metastatic colorectal cancer. According... Continue Reading

FDA Grants Breakthrough Therapy Designation to AP26113 for ALK-Positive NSCLC (10-22-2014)
The U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to an investigational agent AP26113 for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non–small... Continue Reading

Adding Cediranib to Olaparib Markedly Improves Progression-Free Survival but Increases Toxicity in Recurrent Platinum-Sensitive Ovarian Cancer (10-21-2014)
The addition of the antiangiogenic agent cediranib to the PARP inhibitor olaparib in women with recurrent platinum-sensitive ovarian cancer improves time to cancer progression and survival. The results... Continue Reading

More Cancer News

Locations

Binghamton
169 Riverside Drive
Binghamton, NY 13905
(607) 798-5307
Click here to visit the Lourdes website
Johnson City
30 Harrison Street
Johnson City, NY 13790
(607) 763-6850
Click here to visit the UHS website
Office Hours (both locations)
Monday – Thursday 8:00am – 4:30pm
Friday 8:00am- 12:00pm